Development Level Comprehensive Evaluation And Driving Factor Of China Biological Medicine Industry

Biological medicine industry has an irreplaceable role in transforming of the mode of economic growth and adjusting of industrial structure in China.First of all,based on the comprehensive domestic and foreign scholars on the basis of the research of Biological medicine industryfind thatthe Biological medicine industryhas a global,innovative,long-term resistance,radiation four characteristics,its development is primarily influenced by resource endowments,market demand,innovation,and social regulation and other factors.This paper build the operational evaluation index system of Biological medicine industrydevelopment.Base on the theoretical analysis of Biological medicine industry,collecting actual data,and using factor analysis from four to nine dimension level to evaluate including the Biological medicine industry in addition to Hong Kong and Macao and Taiwan Province of 31 provinces.The results show that the level of Biological medicine industry in China can be divided into four echelons,the first tier is the best in all aspects;the second tier performs portion outstanding,but has short-board;the third tier in all aspects of industrial development lagging behind;a fourth echelon lagged behind compared with the first two,especially the first echelon,there is a clear gap.Through empirical study analyzes the driving factors affect the biological stage of development of China's Biological medicine industry and its impact direction.Biological medicine companies on sales of explanatory variables,industrial base,innovation,and market demand,government support for the explanatory variables,using multiple regression method for drivers stage of China's biomedical industry a quantitative analysis.Study found that the present stage driving factors for the development of Biological medicine industryin China both have a positive role in promoting.The government support and innovation investment have the most import influence on biomedicine enterprises in our country,demand side drive smaller role in the market.